Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for ...
Carlyle Group CG is considering acquiring Baxter International's BAX kidney care spinoff, Vantive, in a deal valued at more than $4 billion, including debt. The news was first reported by Wall Street ...
Private equity firm Carlyle Group is reportedly in talks to acquire Baxter's kidney care spinoff for more than $4 billion.
Private-equity firm Carlyle Group is in talks to buy Baxter International's spinoff kidney business, Vantive, The Wall Street Journal reports. The sale of the business could go for more than $4 ...
Baxter stock surges 5% on news of $4 billion deal with Carlyle Group for kidney care unit, potentially ending in sale instead ...
, opens new tab kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters on Friday. Shares of the Deerfield, Illinois-based firm rose ...
Baxter International (NYSE:BAX) rose 4% after a report that private equity firm Carlyle Group (CG) is in talks to acquire the kidney care spinoff for more than $4 billion, including debt.
(Reuters) - Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...